This work aimed to explore the antiradical activity of various ellagitannin metabolites, including Urolithin A (UroA), Urolithin B (UroB), Urolithin C (UroC), and Urolithin D (UroD), in a non-polar (benzene) and polar (water) medium. The antiradical effect of the investigated compounds against reactive oxygen species HO• was evaluated in water (physiological conditions) and benzene, while against CH3OO• and CCl3OO• it was assessed solely in benzene, using the Quantum Mechanics-based Test for Overall Free-radical Scavenging Activity (QM-ORSA) methodology. In non-polar media, compounds UroA, UroC, and UroD exhibit antiradical capabilities against the HO• through Proton-coupled electron transfer (PCET) and Radical Adduct Formation (RAF) processes. Conversely, UroB predominantly exhibits inhibitory activity on HO• through the RAF pathway. On the other hand, the reaction with CH3OO• and CCl3OO• only occurs through the Hydrogen Atom Transfer (HAT). Under physiological conditions, all investigated compounds show antiradical capacity against the HO•, primarily via the SPLET and RCF mechanisms. The reactivity of radical species in both solvents decreases in the following order: HO• > CCl3OO• > CH3OO•. The thermodynamic and kinetic parameters in both solvents indicate that the investigated compounds’ reactivity follows a decreasing order of UroD > UroA > UroC > UroB. Furthermore, newly formed radical species of urolithin exhibit lower reactivity towards the fatty acid model in comparison to investigated reactive radical species, potentially preventing lipid peroxidation initiation. The investigated compounds can regenerate glutathione (GSH) by providing a hydrogen atom to the glutathione radical (GS•), which forms during interaction with highly reactive radical species. In water, tested compounds also regenerate GSH by donating H atoms to GS•, as well as by transferring electrons from dominant acid-base species to GS•, followed by protonation of the resulting GS¯. Urolithins showed similar inhibitory effects as the conventional inhibitors Y-700, FYX-051, and Febuxostat on Xanthine Dehydrogenase (XDH). Reactivity towards XDH enzyme decreases in the following order UroC > UroB > UroD > UroA.